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SENSITIVITY OF DIAGNOSTIC TESTS FOR DRY EYE 
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SUMMARY – Th e aim of the study was to evaluate diagnostic tests for keratoconjunctivitis sicca 
(Schirmer test, tear break-up time (TBUT) test, and corneal staining with fl uorescein and lissamine 
green dye) in patients with blepharospasm. Th is prospective study included 60 female patients older 
than 40 with blepharospasm, divided into two groups according to clinical symptoms. For fl uorescein 
test, the surface under the ROC curve was 1.0 with standard error (SE) 0 and 95% confi dence interval 
(95% CI) 0.940-1.0; for Schirmer test, the surface under the ROC curve was 0.817 with SE 0.0555 
and 95% CI 0.696-0.905; for lissamine green test, the surface under the ROC curve was 0.813 with 
SE 0.056 and 95% CI 0.691-0.902; and for TBUT test, the surface under the ROC curve was 0.772 
with SE 0.061 and 95% CI 0.645-0.870. According to the results of ROC curve, which determines 
the sensitivity and specifi city of normal values, comparison of diagnostic tests for keratoconjunctivitis 
sicca used in this study showed that fl uorescein test had the best sensitivity and specifi city. Schirmer 
test should be avoided in patients with blepharospasm because its results are infl uenced by frequent 
blinking and are not appropriate for study interpretation. Despite the pathologic values of TBUT test 
(numerically), this test is still acceptable for patients with blepharospasm because its interval takes 
more time than the interval between two blinks.
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Introduction
Blepharospasm is a periodical, involuntary contrac-
tion of the orbicular muscle of eye that often remains 
unrecognized (50% of cases in 5 years on up to 3 ex-
aminations)1 and very often confused with dry eye2. 
Blepharospasm patients complain of sand feeling in 
their eyes, eye dryness, and photophobia3-5. On slit 
lamp examination, it is possible to get normal fi nding 
of the anterior eye segment or symptoms of chronic 
conjunctivitis, keratitis or iritis.
Th e most widely used diagnostic tests for tear fi lm 
examination are tear break-up time (TBUT) test, cor-
neal and conjunctival staining with fl uorescein, rose 
bengal and lissamine green dye, Schirmer test, tear 
fi lm osmolarity test and impression cytology.
Schirmer test is the objective test most frequently 
and longest (more than 100 years)6 used in dry eye di-
agnosis, but as it is not standardized7,8, it is inaccurate 
and it cannot be repeated because it causes refl ex se-
cretion with its invasiveness9, measures only tear pro-
duction10, and provides no information on tear evapo-
ration11. However, because of its low price and easy 
performance, it is the most frequently used dry eye 
lacrimal secretory function test12.
Tear break-up time fl uorescein test is widely ac-
cepted in dry eye diagnosis and is considered more re-
liable than Schirmer test as it can be repeated13, and is 
minimally invasive. With this test, it is possible to get 
information on tear evaporation. It is necessary to re-
peat the measurement at least three times and the re-
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sults should be similar. When there are signifi cant dif-
ferences between measurements, the result should be 
interpreted as “TBUT unreliable”. In addition, there 
should be no asymmetry between the results obtained 
on both eyes. Such results probably refl ect unilateral 
secondary cause (for example, bacterial or viral infec-
tion, allergy)14-16 . When TBUT is shorter than the in-
terval between two blinks, it is considered normal for 
the person when awake11, since the healthy eye fre-
quency of blinking is 10-12 times per minute.
Th e lissamine green dye that stains degeneratively 
changed, dead cells and mucous fi brils has been used 
in the evaluation of conjunctival vitality. Typical stain-
ing of bulbar conjunctiva has the shape of two triangles 
with the base on the limbus16. It is important to note 
that staining should not be performed after the use of 
topical anesthetics because of the possible false-posi-
tive results.
Conjunctival and corneal epithelial erosions are 
stained with fl uorescein dye (fl uorescein invades the 
sites of disruption between cell junctions). Pathogno-
monic staining of epithelial erosions in dry eye is bilat-
eral and symmetric, punctate all around the cornea, 
corneal at six o’clock, and conjunctival at the site of 
palpebral rim.
Because of frequent blinking in blepharospasm, we 
wondered whether particular diagnostic tests would 
prove valuable in the diagnosis of dry eye in patients 
with blepharospasm due to their questionable use (e.g., 
TBUT, Schirmer test, etc.) or would yield false-nega-
tive results (such as corneal fl uorescein test).
Materials and Methods
Th is prospective study conducted from January 
2004 until December 2009 included 60 female pa-
tients older than 40 and divided into two groups ac-
cording to their clinical symptoms. Th e fi rst group in-
cluded patients with grade I or II blepharospasm with 
predominating symptomatology of dry eye, also serv-
ing as control group. Th e second group included pa-
tients with grade III or IV blepharospasm requiring 
medical therapy. All patients that needed medical 
therapy were treated, after obtaining their informed 
consent, with botulinum neurotoxin type A injection, 
which is today considered the therapy of choice17,18. 
Th e patients with glaucoma or ocular hypertension 
prior to or acquired during the study period were ex-
cluded due to constant use of topical antiglaucoma 
medication because of the possible occurrence of ocu-
lar surface defects. Patients having undergone surgical 
procedures on the anterior or posterior segment of the 
eye, as well as those in whom botulinum neurotoxin 
type A was contraindicated were also excluded from 
the study.
In dry eye diagnosis, we used the following special 
tests:
Schirmer test
A method of double washing up (double-void tech-
nique) with measurement of tear fi lm water component. 
Result interpretation: >10 mm – normal secretion; 5-10 
mm – borderline result; <5 mm – probable hyposecre-
tion dry eye; and <3 mm – hyposecretion dry eye.
Tear break-up time (TBUT)) test
Tear fi lm stability measurement – relevant fi nding 
is development of multiple and diff use black spots or 
lines in the tear fi lm19-22. Result interpretation: interval 
TBUT test shorter than 10 s – dry eye diagnosis is 
considered; and interval TBUT test shorter than 5 s – 
dry eye diagnosis is highly probable.
Ocular surface staining with 1% fl uorescein solution
Th e National Eye Institute (NEI)/Industry Work-
shop scale was used for evaluation of the amount of 
ocular surface staining with fl uorescein23. Th e cornea 
was divided into fi ve and conjunctiva into three areas, 
and staining in each particular area was evaluated from 
0 to 3 up to the maximum of 15 points.
Assessment of conjunctival vitality by lissamine green 
staining, which stains degenerative, dead cells and mu-
cous fi brils. Staining profi le typical for bulbar conjunc-
tiva is triangle shaped with its base on the limbus16.
Van Bijsterveld score10 was used on result interpre-
tation. Th e interpalpebral region is divided into three 
areas: temporal conjunctiva, nasal conjunctiva, and 
central cornea. Each of these areas is further graded 
into three stages: low, moderate, and severe. Total score 
is calculated for each eye, maximum score is 9. A score 
of 3.5 or more indicates keratoconjunctivitis sicca.
Statistics
Th e mean values of continuous variables were ex-
pressed by arithmetic mean and standard deviation for 
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normally distributed variables, and by median and 
range for unequally distributed variables. Nominal in-
dicators were shown by frequency distribution accord-
ing to groups and share. Mann-Whitney test was used 
to determine diff erences between two independent 
samples. Th e level of signifi cance was set at α=0.05.
Results
During the study, the following tests were per-
formed on our subjects: fl uorescein staining test on 
both eyes, lissamine dye staining test on both eyes, 
TBUT test on both eyes, and Schirmer test on both 
eyes (Table 1). Diff erences in the measured values were 
signifi cant for all parameters except for fl uorescein test 
for left eye. Th ere was no statistically signifi cant diff er-
ence in the measured values of ophthalmological tests 
according to age groups (Table 2).
Th e validity of fl uorescein test was assessed by the 
Receiver Operating Characteristic (ROC) curve, 
where the sensitivity and specifi city based on normal 
values are determined. Th e surface under the curve is 
the measure of test accuracy. For fl uorescein test, the 
surface under the ROC curve was 1.0, with standard 
error (SE) 0 and 95% confi dence interval (95% CI) 
0.940-1.0. Since the surface under the curve was in the 
0.9-1.0 interval, this test was considered an excellent 
test for diff erentiating control group from intervention 
group of patients. TBUT test yielded the area under 
the ROC curve of 0.772 with SE 0.061 and 95% CI 
0.645-0.870. Since the area under the ROC curve 
measures the accuracy of the test, the value of 0.772 












FL test right eye 3 (2.75-3) 4 (4-4) <0.001
FL test left eye 4 (4-4) 4 (4-4) 0.078
TBUT right eye 3.5 (3-4) 2.5 (2-3) 0.001
TBUT left eye 4 (3-4) 2.5 (2-3) <0.001
Lissamine green 
test
7 (5.75-7) 5 (4-5.25) <0.001
Schirmer test 
for both eyes
2 (1-2) 1 (1-1) <0.001
*Mann-Whitney test; FL = fl uorescein test; TBUT = tear break-up 
time test






FL test 0.792 0.999
TBUT test 0.297 0.074
Lissamine test 0.031 0.974
Schirmer test 0.104 0.988
*Kruskal Wallis test; FL = fl uorescein test; TBUT = tear break-up 
time test
FL = fl uorescein test; TBUT = tear break-up time test
Fig. 1. Comparison of specifi city and sensitivity 
























95% Confi dence 
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FL test 1.0 0 0.940-1.0







FL = fl uorescein test; TBUT = tear break-up time test
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indicated TBUT to be a mediocre test for group dif-
ferentiation. Schirmer test yielded the area under the 
ROC curve of 0.817 with SE 0.0555 and 95% CI 
0.696-0.905. Lissamine green test yielded the area 
 under the ROC curve of 0.813 with SE 0.056 and 
95% CI 0.691-0.902 (Table 3, Fig. 1).
Besides specifi city and sensitivity, for every oph-
thalmologic test there are defi ned border criterion 
(cut-off ) values and values of criterion predictor (the 
ratio of probability that the result will be positive or 
negative and positive and negative predictive values) 
(Table 4). Th e probability ratio tells us what is the 
probability of the expected outcome of the diagnostic 
test in the control group of patients as compared with 
the intervention group.
Predictive value shows how many times (%) the 
value measured with the test was the real value. It was 
highest in fl uorescein test and lowest in TBUT test. 
All these data proved that fl uorescein test had highest 
sensitivity and TBUT test lowest sensitivity (Fig. 1).
An overview of statistical signifi cance among ROC 
curves for all ophthalmologic tests is shown in Table 5.
Discussion
Th e study included only female patients since the 
disease is more common in female population (female 
to male ratio, 3:1). Epidemiological studies report that 
dry eye, which is present in almost all blepharospasm 
patients, is also more common in female population, 
especially postmenopausal24 and elderly25-28 women. In 
order to avoid the possible diff erences in result inter-
pretation, which are caused by hormonal diff erences in 
dry eye symptoms, only female subjects were included 
in the study.
Patients suff ering from glaucoma were excluded 
from the study, as it is well known that long-term use 
of antiglaucoma drugs may change ocular surface and 
tear fi lm function. Th ese changes can be caused by the 
drugs themselves, preservatives in commercial prepa-
rations, or by long duration of local therapy. Th e clini-
cal eff ect on ocular changes is unknown29-34. Herreras 
et al. showed that 66% of patients having used local 
timolol therapy for 25 months and more had patho-
logic Schirmer test, while TBUT was shorter than 10 
s in 95% of cases34.
Dry eye diagnosis is usually based on history data 
and diagnostic tests such as TBUT, Schirmer test, rose 
bengal (lissamine green) or fl uorescein dye staining of 
conjunctiva and cornea, impression cytology, punctate 
epithelial keratopathy, and fi lamentous keratitis. Al-
though simple to perform, impression cytology is not 
widely spread as a diagnostic method in clinical prac-
tice in dry eye diagnosis. It requires cooperation with 
Table 5. Statistical signifi cance of ROC curves between 
ophthalmologic tests used
Tests compared Z p
FL test – TBUT test 3.742 <0.001
FL test – Schirmer test 3.302 0.001
FL test – Lissamine green test 3.341 0.001
TBUT test – Schirmer test 0.581 0.561
TBUT test – Lissamine green test 0.555 0.579
Schirmer test – Lissamine green 
test
0.051 0.959
FL = fl uorescein test; TBUT = tear break-up time test
Table 4. Border criterion values of ophthalmologic tests
Value FL test TBUT test Schirmer test
Lissamine 
green test
Border criterion value 3.5 3 1 5
Sensitivity 100 90 100 76.67
Specifi city 100 56.67 63.33 76.67
Probability ratio
Positive 0 2.08 2.73 3.29
Negative 0 0.18 0 0.30
Predictive value
Positive 100 67.5 73.2 76.7
Negative 100 85.0 100 76.7
FL = fl uorescein test; TBUT = tear break-up time test
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cytologists and it is not practical in clinical work, prob-
ably because almost all dry eye patients also have squa-
mous metaplasia.
Khanal et al.33 carried out a study in which they 
evaluated individual diagnostic tests in the diagnosis 
of dry eye. In addition to standard tests (Schirmer test, 
TBUT, fl uorescein and rose bengal test), they also per-
formed specifi c measurements of osmolarity and evap-
oration, and meibomian gland function analysis. Th e 
authors found the measurement of osmolarity to be 
the best test for the diagnosis of dry eye, although 
Schirmer test is the most widely used test (for over 100 
years). However, the former test is very expensive and 
therefore not widely usable in clinical practice.
Schirmer test certainly has its place in the diagnosis 
of dry eye, but the person who performs it needs to 
know what is actually measured by this test, i.e. only 
and exclusively the aqueous component of tear fi lm. 
Generalizing the results of the entire tear fi lm is com-
pletely wrong and this test cannot be used alone in the 
diagnosis of dry eye. In addition, in patients with 
blepharospasm, this test should be avoided, as it is dif-
fi cult to perform it properly because of the nature of the 
disease. Schirmer test, although the oldest test used in 
dry eye diagnosis, should be avoided in patients with 
benign essential blepharospasm because of question-
able performing it correctly. Th e test measures only tear 
fi lm water component and if there is suspicion of hypo-
secretion dry eye (for example, a combination of benign 
essential blepharospasm and Sjögren’s syndrome), it 
should be performed during the asymptomatic stage of 
the disease, but not right after botulinum toxin applica-
tion because it also infl uences tear secretion.
In our study, all subjects had the result of Schirmer 
test above 5 mm, suggesting that these patients did not 
have hyposecretion dry eye. Schirmer test result be-
tween 5 and 10 mm (borderline result) was recorded in 
63.3% of control group and 3.3% of intervention group 
subjects. It is interesting to note that 96.7% of the in-
tervention group subjects had Schirmer test result 
above 10 mm, indicating that performing this test in 
the intervention group was questionable. Schirmer test 
is correctly performed only when the subject is calm 
and does not talk or move the eyeballs under closed 
eyelids, which is practically impossible in blepharo-
spasm patients, especially those with grade III or IV.
Every form of dry eye disease is associated with in-
creased tear osmolarity and decreased tear fi lm stabil-
ity. Th erefore, measuring tear fi lm stability is highly 
relevant in dry eye diagnosis, as also demonstrated in 
this study. Unfortunately, TBUT does not have good 
reputation because of its unreliability and high result 
variability, and results are neither reproducible nor 
comparable. However, the main reason is that the test 
is performed in many ways that have not been stan-
dardized and therefore the results are incomparable. 
TBUT test can be performed with or without fl uores-
cein. Fluorescein is used although it can destabilize 
tear fi lm21,35,36 . However, with careful instillation of 
fl uorescein in the conjunctival bag and avoiding refl ex 
secretion induction, this infl uence on tear fi lm can be 
avoided37. Diff erence of TBUT results between the 
two groups was statistically signifi cant. Despite patho-
logic TBUT results in both groups, especially in the 
intervention group, it was concluded that these results 
were normal. Ousler et al. think that if TBUT is short-
er than the interval between two blinks, TBUT for 
that person is normal when awake, considering that 
healthy eye frequency of blinking is 10-12 times per 
minute16.
Dry eye diagnosis also uses 1% fl uorescein dye 
staining that stains surface epithelial erosions, and ben-
gal rose and lissamine green dye staining that stains 
degeneratively changed or dead epithelial cells21,36,38 . 
Defi ciency of these tests is that they show superfi cial 
eye erosions, they are not appropriate for early dry eye 
disease detection, and cannot diff erentiate dry eye from 
other conditions that have ocular surface staining38-40. 
In this study, fl uorescein and lissamine green were used 
for staining the surface of the eye. Khurana et al. report 
that staining with bengal red and lissamine green gives 
comparable results but staining with lissamine green is 
less irritating to patients38. Th ese results were also con-
fi rmed by Manning et al., who compared tolerability of 
these dyes in patients and characteristics of ocular sur-
face staining in keratoconjunctivitis sicca39.
Comparing diagnostic tests for keratoconjunctivi-
tis sicca used in this study according to ROC curve 
that determines the sensitivity and specifi city based on 
normal values, we found fl uorescein test to have high-
est and TBUT test lowest sensitivity and specifi city. 
We could explain low sensitivity and specifi city of 
TBUT test with diffi  culty to perform it correctly be-
cause of the nature of the disease. Despite pathologic 
TBUT test results (numerically), they are not consid-
ered to be a problem in patients with benign essential 
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blepharospasm (especially grade III or IV) because 
they are often longer than the interval between two 
blinks.
Schirmer test should be avoided in patients with 
blepharospasm because frequent blinking aff ects the 
test reliability and hence we could not demonstrate 
that it would have an impact on the disease prognosis 
and therapy protocol. Despite the pathologic values of 
TBUT test (numerically), this test is still acceptable 
for patients with blepharospasm because its interval 
takes more than the interval between two blinks.
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Sažetak
OSJETLJIVOST DIJAGNOSTIČKIH TESTOVA ZA SUHO OKO 
KOD BOLESNIKA S BLEFAROSPAZMOM
D. Biuk, M. Vinković, S. Matić, M. Bradvica, E. Biuk i T. Benašić
Cilj istraživanja bio je usporediti dijagnostičke testove za konjunktivitis sicca (Schirmerov test, test raskidanja suznog 
fi lma (engl. tear break-up time test, TBUT) i testove bojanja rožnice fl uoresceinom i zelenom bojom lisamin) kod bolesnika s 
blefarospazmom. Prospektivnom studijom obuhvaćeno je šezdeset ispitanica starijih od četrdeset godina kojima je dijagno-
sticiran blefarospazam. Ispitanice su podijeljene u dvije skupine ovisno o kliničkim simptomima. Površina ispod krivulje 
ROC za fl uoresceinski test iznosila je 1,0 uz standardnu grešku (SE) 0 i interval pouzdanosti (95% CI) 0,940-1,0; za Schir-
merov test je površina ispod krivulje ROC iznosila 0,817 uz SE 0,0555 i 95% CI 0,696-0,905; za test sa zelenom bojom 
 lisamin površina ispod krivulje ROC bila je 0,813 uz SE 0,056 i 95% CI 0,691-0,902; te za test TBUT je površina ispod 
krivulje ROC bila 0,772 uz SE 0,061 i 95% CI 0,645-0,870. U studiji je prema rezultatima krivulje ROC, kojom se utvr đuje 
osjetljivost i specifi čnost normalnih vrijednosti, fl uoresceinski test imao najbolju osjetljivost i specifi čnost u usporedbi s dru-
gim testovima koji se primjenjuju u dijagnosticiranju suhog keratokonjunkitivitisa. Izvođenje Schirmerova testa ne preporu-
ča se u bolesnika s keratokonjunktivitisom sicca i blefarospazmom zbog čestog treptanja, što može utjecati na rezultate testa 
i njegovu pravilnu interpretaciju. Unatoč patološkim brojčanim vrijednostima TBUT test je prihvatljiv za kliničku primjenu 
u bolesnika s keratokonjunktivitisom i blefarospazmom, jer je interval raskidanja suznog fi lma duži od vremenskog intervala 
između dva treptaja.
Ključne riječi: Bojenje i označavanje preparata; Blefarospazam; Flourescein; Lisamin, zelena boja; Krivulja ROC; Hrvatska
